Godlike Productions - Reply to Thread

Users Online Now: 2,078 (Who's On?)	Visitors Today: 1,951,204
Pageviews Today: 2,882,557	Threads Today: 789	Posts Today: 16,361
11:28 PM

REPLY TO THREAD

Subject Vaccine Injury Compensation Program ( VICP ) does not umbrella the SARS-COV-2 Vaccine during Prep Act, see CICP Program

User Name

Font color: Font:

In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 50% of the source material, provide a link back to the original article and provide your original comments / criticism in your post with the article.

[quote:Anonymous Coward 77549249:MV80NTQzMzMyX0Y3NzAxMDdB]
Prep Act was declared in February 2020.... Only the [b]Countereasure Insurance Compendation Program (CICP)[/b] umbrellas the EUAs ( Emergency Use Authorizations ) , Antiviral drugs, Vaccines , etc ....

PREP Act Q&As
The [b]Public Readiness and Emergency Preparedness Act (PREP Act) [/b]added new legal authorities to the Public Health Service (PHS) Act to provide [b]liability immunity [/b]related to the manufacture, testing, development, distribution, administration and use of medical countermeasures against chemical, biological, radiological and nuclear agents of terrorism, epidemics, and pandemics.   It also added authority to establish a program to compensate eligible individuals who suffer injuries from administration or use of products covered by the PREP Act’s immunity provisions. 
 
The following is intended to address frequently asked questions from the manufacturing industry, the healthcare community, and state and local government officials about the PREP Act.  It is not an exhaustive review of the PREP Act’s provisions in all contexts or a protocol for the HHS’s implementation of the PREP Act.  In addition, other legal protections may be available at the federal, state, and local government level.
 
Overview
The PREP Act authorizes the [b]Secretary of the Department of Health and Human Services (Secretary) (HHS) [/b]to issue a [b]PREP Act Declaration (“Declaration”)[/b] that provides immunity from liability for any loss caused, arising out of, relating to, or resulting from administration or use of countermeasures to diseases, threats and conditions determined in the Declaration to constitute a present or credible risk of a future public health emergency.  In general, the liability immunity applies to entities and individuals involved in the development, manufacture, testing, distribution, administration, and use of medical countermeasures described in a Declaration.  The only statutory exception to this immunity is for actions or failures to act that constitute willful misconduct.  A PREP Act Declaration is specifically for the purpose of providing immunity from liability, and is different from, and not dependent on, other emergency declarations issued by HHS or other government agencies.   The PREP Act also authorizes a fund in the United States Treasury to provide compensation to eligible individuals for serious physical injuries or deaths directly caused by administration or use of a countermeasure covered by the Declaration.
[/quote]

Original Message Prep Act was declared in February 2020.... Only the Countereasure Insurance Compendation Program (CICP) umbrellas the EUAs ( Emergency Use Authorizations ) , Antiviral drugs, Vaccines , etc ....

PREP Act Q&As
The Public Readiness and Emergency Preparedness Act (PREP Act) added new legal authorities to the Public Health Service (PHS) Act to provide liability immunity related to the manufacture, testing, development, distribution, administration and use of medical countermeasures against chemical, biological, radiological and nuclear agents of terrorism, epidemics, and pandemics. It also added authority to establish a program to compensate eligible individuals who suffer injuries from administration or use of products covered by the PREP Act’s immunity provisions.

The following is intended to address frequently asked questions from the manufacturing industry, the healthcare community, and state and local government officials about the PREP Act. It is not an exhaustive review of the PREP Act’s provisions in all contexts or a protocol for the HHS’s implementation of the PREP Act. In addition, other legal protections may be available at the federal, state, and local government level.

Overview
The PREP Act authorizes the Secretary of the Department of Health and Human Services (Secretary) (HHS) to issue a PREP Act Declaration (“Declaration”) that provides immunity from liability for any loss caused, arising out of, relating to, or resulting from administration or use of countermeasures to diseases, threats and conditions determined in the Declaration to constitute a present or credible risk of a future public health emergency. In general, the liability immunity applies to entities and individuals involved in the development, manufacture, testing, distribution, administration, and use of medical countermeasures described in a Declaration. The only statutory exception to this immunity is for actions or failures to act that constitute willful misconduct. A PREP Act Declaration is specifically for the purpose of providing immunity from liability, and is different from, and not dependent on, other emergency declarations issued by HHS or other government agencies. The PREP Act also authorizes a fund in the United States Treasury to provide compensation to eligible individuals for serious physical injuries or deaths directly caused by administration or use of a countermeasure covered by the Declaration.

Pictures (click to insert)





\| Next Page >>